SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001193125-17-262349
Filing Date
2017-08-18
Accepted
2017-08-18 17:22:45
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-1 d442134ds1.htm S-1 574708
2 EX-5.1 d442134dex51.htm EX-5.1 5629
3 EX-10.18 d442134dex1018.htm EX-10.18 173482
4 EX-23.1 d442134dex231.htm EX-23.1 1598
5 GRAPHIC g442134g0817071753404.jpg GRAPHIC 3156
6 GRAPHIC g442134g0817071753575.jpg GRAPHIC 50221
7 GRAPHIC g442134g0817071753825.jpg GRAPHIC 46659
8 GRAPHIC g442134g0817071754184.jpg GRAPHIC 4375
9 GRAPHIC g442134g40x21.gif GRAPHIC 4691
10 GRAPHIC g442134g85n67.gif GRAPHIC 3087
  Complete submission text file 0001193125-17-262349.txt   911806
Mailing Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752
Business Address 257 SIMARANO DRIVE SUITE 101 MARLBOROUGH MA 01752 (508) 767-3861
RXi Pharmaceuticals Corp (Filer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-220062 | Film No.: 171041729
SIC: 2834 Pharmaceutical Preparations